Infectious Complications Associated with CAR T-Cell Therapy

被引：7

作者：

Mikkilineni, Lekha ^{[1
]}

Shahani, Shilpa ^{[2
]}

Yates, Bonnie ^{[3
]}

Steinberg, Seth M. ^{[4
]}

Palmore, Tara ^{[5
]}

Nussenblatt, Veronique ^{[6
]}

Lee, Daniel W. ^{[7
]}

Kaplan, Rosandra N. ^{[8
]}

Mackall, Crystal L. ^{[9
,10
]}

Fry, Terry J. ^{[11
,12
]}

Gea-Banacloche, Juan ^{[13
]}

Jerussi, Theresa ^{[14
]}

Kochenderfer, James N. ^{[15
]}

Shah, Nirali N. ^{[16
]}

机构：

[1] NCI, Med Oncol Hematol Fellowship, Washington, DC USA

[2] NIH, Pediat Oncol Branch, Ctr Canc Res, Bldg 10, Bethesda, MD 20892 USA

[3] NCI, Pediat Oncol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA

[4] NCI, Biostat & Data Management Sect, Ctr Canc Res, NIH, Bethesda, MD 20892 USA

[5] NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA

[6] NIAID, Infect Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA

[7] Univ Virginia, Dept Pediat, Div Pediat Hematol Oncol, Charlottesville, VA USA

[8] NIH, Pediat Oncol Branch, Ctr Canc Res, Bldg 10, Bethesda, MD 20892 USA

[9] Stanford Univ, Sch Med, Stanford Canc Inst, Stanford, CA 94305 USA

[10] NCI, NIH, Stanford, CA USA

[11] NCI, CCR, NIH, Aurora, CO USA

[12] NCI, CCR, POB, NIH, Bethesda, MD 20892 USA

[13] Mayo Clin, Dept Infect Dis, Phoenix, AZ USA

[14] NIH, Bldg 10, Bethesda, MD 20892 USA

[15] NCI, Expt Transplantat & Immunol Branch, Ctr Canc Res, Bethesda, MD 20892 USA

[16] NCI, Pediat Oncol Branch, NIH, Bethesda, MD 20892 USA

来源：

BLOOD | 2019年 / 134卷

关键词：

D O I：

10.1182/blood-2019-131170

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

4449

引用

页数：3

共 50 条

[1] Infectious complications of CAR T-cell therapy: a clinical update
Stewart, Adam G.
Henden, Andrea S.
THERAPEUTIC ADVANCES IN INFECTIOUS DISEASE, 2021, 8
[2] Influence of CAR T-cell therapy associated complications
Umair, Mohammad Mussab
Lai, Xun
Xue, Yuanbo
Yao, Hong
FRONTIERS IN ONCOLOGY, 2025, 15
[3] Infectious complications of car T-cell therapy: A longitudinal risk model
Czapka, Michael T.
Riedell, Peter A.
Pisano, Jennifer C.
TRANSPLANT INFECTIOUS DISEASE, 2023, 25
[4] Infectious complications of car T-cell therapy: A longitudinal risk model
Czapka, Michael T.
Riedell, Peter A.
Pisano, Jennifer C.
TRANSPLANT INFECTIOUS DISEASE, 2023, 25
[5] Infectious Complications of CAR T-Cell Therapy in Non-Hodgkin Lymphoma
Hayne, Justin
Kubusek, Jilan
Tosh, Pritish K.
Bennani, Nora N.
Lin, Yi
Ansell, Stephen
Bisneto, Jose Villasboas
Nedved, Adrienne
Paludo, Jonas
Johnston, Patrick B.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : S275 - S275
[6] Impact of Bridging Therapy on Infectious Complications Post CAR T-Cell Therapy: The UT Southwestern Experience
Patel, Akshat M.
Lue, Brian
Reves, Heather
Afrough, Aimaz
Anderson, Larry D.
Chung, Stephen S.
Collins, Robert H.
Kaur, Gurbakhash
Kumar, Kiran A.
Madanat, Yazan F.
Vusirikala, Madhuri
Awan, Farrukh T.
Tessier, Jeffrey M.
Geethakumari, Praveen Ramakrishnan
BLOOD, 2022, 140 : 12793 - 12795
[7] Infectious complications of chimeric antigen receptor (CAR) T-cell therapies
Gea-Banacloche, Juan C.
SEMINARS IN HEMATOLOGY, 2023, 60 (01) : 52 - 58
[8] Infectious complications of CAR T-cell therapy across novel antigen targets in the first 30 days
Mikkilineni, Lekha
Yates, Bonnie
Steinberg, Seth M.
Shahani, Shilpa A.
Molina, John C.
Palmore, Tara
Lee, Daniel W.
Kaplan, Rosandra N.
Mackall, Crystal L.
Fry, Terry J.
Gea-Banacloche, Juan
Jerussi, Theresa
Nussenblatt, Veronique
Kochenderfer, James N.
Shah, Nirali N.
BLOOD ADVANCES, 2021, 5 (23) : 5312 - 5322
[9] Infectious complications in patients with relapsed refractory multiple myeloma after BCMA CAR T-cell therapy
Kambhampati, Swetha
Sheng, Ying
Huang, Chiung-Yu
Bylsma, Sophia
Lo, Mimi
Kennedy, Vanessa
Natsuhara, Kelsey
Martin, Thomas
Wolf, Jeffrey
Shah, Nina
Wong, Sandy W.
BLOOD ADVANCES, 2022, 6 (07) : 2045 - 2054
[10] CAR T-cell therapy-associated neurotoxicity
Reactions Weekly, 2020, 1818 (1) : 5 - 5

← 1 2 3 4 5 →